Develop and execute global medical affairs strategy and tactical plans for lead investigational asset
Establish long-term medical affairs plans supporting regulatory submissions, launch, and lifecycle management
Lead medical launch preparation across major markets with commercial, market access, HEOR, regulatory, clinical development, and regional medical teams
Guide development of scientific platforms, medical training materials, medical information resources, publication plans, congress activities
Collaborate with HEOR and market access teams on payer engagement and value communication
Build relationships with global KOLs, clinical investigators, professional societies, patient advocacy organizations
Lead scientific advisory boards and expert consultations
Represent organization at scientific congresses and industry meetings
Provide strategic direction for scientific communication, publications, disease education, medical training
Review externally facing scientific materials for accuracy and compliance
Represent medical affairs on cross-functional asset team
Requirements
MD, PharmD, PhD, or equivalent advanced degree
At least 10 years medical affairs leadership experience; 5+ years global preferred
Therapeutic expertise in neuroscience, sleep medicine, neurology, psychiatry, or rare diseases
Demonstrated leadership in at least one successful global product launch; North America, Europe, Asia-Pacific preferred
Experience as global medical lead for late-stage programs or commercial products
Understanding of medical affairs strategy, evidence generation, payer evidence, medical communications
Strategic and business acumen
Cross-functional leadership in matrix organizations